Key Takeaways HIMS has delivered over 30 million telehealth consultations across the United States and the U.K. to date. HIMS offers care for mental health, dermatology, sexual wellness and weight management via its app. HIMS is expanding into lab testing, compounded meds, and personalized digital wellness solutions.The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS) , continues to shape the future of health and wellness by integrating clinical excellence with a consumer-first digit ...

Core Insights - The United Kingdom telehealth market was valued at USD 21.56 Billion in 2024 and is projected to grow at a CAGR of 12.10%, reaching USD 67.56 Billion by 2034, driven by increased internet access and smartphone penetration [2][10] - Strong policy support from the NHS and the UK government is facilitating the adoption of telehealth services, ensuring funding and integration within public healthcare frameworks [2] Market Growth Drivers - The UK government announced an investment of up to EUR 600 million (USD 764 million) for a centralized Health Data Research Service, aimed at enhancing data access for researchers and accelerating clinical trials, which is expected to significantly boost telehealth market growth [4] - Rising demand for remote inpatient care and AI-driven solutions, such as Teladoc's AI-powered Virtual Sitter, are enhancing patient safety and care efficiency, contributing to market value growth [5] - User-centric telehealth platforms, like Doctorsa's global telehealth platform, are addressing increasing wait times for GP appointments and improving patient satisfaction, thereby driving market development [5] Market Trends - AI-powered tools for women's health, such as Moody's mental health tool, are expanding the telehealth market by providing personalized care solutions [8] - Investment in virtual wards, exemplified by West Suffolk NHS Foundation Trust's tender for remote patient monitoring services, is expected to enhance clinical outcomes and operational efficiency [8] - Digital therapeutics are gaining traction, offering validated software-based interventions for chronic conditions, supported by NHS initiatives [8] Market Segmentation - The services segment is anticipated to lead the market due to its role in enabling seamless virtual care delivery, particularly in managing chronic diseases and elderly care [8] - England is expected to dominate the market, supported by a robust NHS digital infrastructure and a high urban population, while Scotland, Wales, and Northern Ireland are progressing at varying rates [8] Key Players - Major companies in the UK telehealth market include Doctor Care Anywhere, Teladoc Health, Livi, Babylon Health, Medicspot, Push Doctor, eConsult Health, Cisco Systems Inc., and Codal [7][19]

LAS VEGAS, June 26, 2025 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show, today announced its MARKET.live division will produce and host a high-profile Walmart livestream shopping event for gut-health brand BelliWelli. The exclusive livestream will air on Walmart.com on Tuesday, July 1, 2025, at 4 ...

Core Insights - Hims & Hers Health Inc announced the acquisition of ZAVA, a European digital health platform, which impacted its stock performance in premarket trading [1] - Hims stock experienced volatility, trading as high as $67.35 but later declining by 2.5% to $55.37, while still showing a 128% year-to-date gain [2] - Doximity Inc saw a 3.9% increase in stock price to $53.50, with a recent upgrade from BTIG to "buy" from "hold," and a year-over-year increase of 93.6% [3] - Teladoc Health Inc's stock rose by 2.9% to $7.07, but it remains 22.2% lower year-to-date and far from its February 2021 highs of nearly $300 [4] - The options market shows a strong preference for call options, with a call/put volume ratio of 17.12, indicating a bullish sentiment among investors [5] Company Summaries - Hims & Hers Health Inc is focusing on expanding its digital health services through the acquisition of ZAVA, which may enhance its market position [1] - Doximity Inc is recovering from previous lows, with a significant year-over-year increase and a recent positive analyst rating, suggesting potential for further growth [3] - Teladoc Health Inc is struggling with a significant year-to-date deficit, indicating challenges in regaining its previous high market valuation [4] Market Trends - The telehealth sector is experiencing varied stock performances, with some companies like Hims and Doximity showing strong gains, while others like Teladoc are facing declines [2][4] - The options market reflects a bullish outlook for telehealth stocks, with a notable preference for call options over puts, suggesting investor confidence in future price increases [5]

Company Overview - Hims & Hers Health, Inc is a telehealth platform that provides a variety of health and wellness services, connecting consumers with healthcare professionals [1] - The company offers tailored prescriptions, non-prescription products, and additional services [1] Analyst Background - The analysis is conducted by a qualified accountant with extensive experience in financial services, including private equity, hedge funds, asset management, and venture capital [1] - The analyst has developed skills in financial analysis, risk assessment, and identifying investment opportunities across various companies [1] Disclosure Information - The analyst has no current stock, option, or similar derivative positions in any of the companies mentioned and does not plan to initiate any such positions within the next 72 hours [1] - The article reflects the analyst's personal opinions and is not compensated by any company mentioned [1]

Core Insights - Virtual healthcare services, or telehealth, are becoming a standard in the digital healthcare space, with companies like Hims & Hers Health, Inc. (HIMS) and American Well Corporation (AMWL) emerging as key players in medical consultations and digital health solutions [1][2] Stock Performance & Valuation - HIMS has outperformed AMWL over the past three months, with a 35.1% increase compared to AMWL's 22.3% decline. In the past year, HIMS has rallied 183%, while AMWL has seen a decline of 20.3% [3] - HIMS is trading at a forward 12-month price-to-sales (P/S) ratio of 4.6X, above its three-year median of 2.3X. In contrast, AMWL's forward sales multiple is at 0.4X, below its median of 1.3X [4] Growth Potential for Hims & Hers - HIMS is expanding into new conditions treatable via telehealth, focusing on areas like sleep disorders and hypertension, which align with its business model [7] - HIMS has partnered with Novo Nordisk to enhance accessibility to obesity care, launching a six-month Wegovy access plan at $549/month [8] - Over 65% of new subscribers in 2024 benefited from personalized products, aided by the MedMatch AI tool for customized treatment plans [9] Growth Potential for Amwell - Amwell's platform allows clients to utilize their provider networks for virtual care across various modalities, from primary to specialty care [10] - The Converge platform enables care across in-person, virtual, and automated modalities, supporting interoperability with EHRs [11] - Amwell has a nationwide clinical coverage with around 1,000 active behavioral health providers and partnerships with organizations like the Cleveland Clinic [12] Earnings Projections - The Zacks Consensus Estimate for HIMS' 2025 earnings per share suggests a 166.7% improvement from 2024 [13] - The Zacks Consensus Estimate for AMWL's 2025 loss per share implies a 49.7% improvement from 2024 [15] Price Targets - The average price target for HIMS is $43.00, indicating a potential decline of 17.9% from the last close [17] - The average price target for AMWL is $10.00, suggesting a potential increase of 44.7% from the last close [18] Investment Recommendation - HIMS is viewed as a more stable and financially sound investment opportunity, with strong profitability and user engagement, generating substantial free cash flow [21] - AMWL is recognized for its rapid growth and expansion but is considered a lower-ranked investment option compared to HIMS [22]

RFK Jr. calls for a “revolution” in telehealth and AI to reduce ER visits and improve at-home care.Treatment.com AI and Rocket Doctor applaud the remarks, citing strong alignment with their mission.Rocket Doctor is currently empowering physicians to run their own practices in New York and California, serving Medicaid and Medicare patients in underserved communities. ‏VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) and Rocket Doctor, ...

LAS VEGAS, May 09, 2025 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show, today announced that VERB CEO Rory J. Cutaia will host a conference call to discuss the Company’s financial results for the first quarter 2025 on Tuesday, May 13, 2025, at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). Fin ...

Core Insights - PetMed Express, Inc. has announced a strategic partnership with Dutch to enhance its pet healthcare ecosystem by providing affordable and accessible veterinary care options [1][2] - The collaboration aims to address the nationwide veterinarian shortage, which has left over 129 million Americans without easy access to pet care [2][3] Company Overview - PetMed Express, Inc. is a leader in the consumer pet healthcare sector, offering a wide range of pharmaceuticals, generics, compounded medications, and OTC supplements through its online platforms [4] - The company operates under the brands PetMeds and PetCareRx, delivering services across all fifty states [4] Partnership Details - The partnership allows pet parents to sign up for a monthly Dutch membership, providing virtual access to veterinarians for 24/7 appointments in 34 states [2] - Dutch has completed nearly 700,000 visits and treats over 150 conditions, including flea and tick medication and treatments for allergies and joint pain [2] Industry Context - The 2025 State of Veterinary Care Report indicates that approximately 38% of the U.S. population lives in areas lacking adequate veterinary care, highlighting the need for telehealth solutions [3] - Dutch, launched in July 2021, connects licensed veterinarians with pet owners and has expanded its services to include prescription medications, addressing the critical vet shortage in the U.S. [5]

LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live, VANITYPrescribed, GoodGirlRx, and the GO FUND YOURSELF TV Show, today announced that CEO Rory J. Cutaia was featured on Cheddar TV's Power Players live from the floor of the NY Stock Exchange on an episode that airs Friday, May 9, 2025, at 8PM ET. Hosted by J.D. Durkin, Power Players dive ...